Berberine was neuroprotective against an in vitro model of brain ischemia: Survival and apoptosis pathways involved

Brain Research

Volumn 1557, Issue , 2014, Pages 26-33

  Simões Pires, Elisa Nicoloso ^a   Frozza, Rudimar Luiz ^b   Hoppe, Juliana Bender ^a   Menezes, Bruna De Melo ^a   Salbego, Christianne Gazzana ^a  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

Akt GSK3 ERK; Berberine; Caspase 3; JNK; Neuroprotection; Oxygen and glucose deprivation

Indexed keywords

BERBERINE; CASPASE 3; GLUCOSE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; OXYGEN; PROPIDIUM IODIDE; PROTEIN KINASE B; CASP3 PROTEIN, RAT; GLYCOGEN SYNTHASE KINASE 3; GLYCOGEN SYNTHASE KINASE 3 BETA; NEUROPROTECTIVE AGENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; BRAIN ISCHEMIA; CELL SURVIVAL; FLUOROMETRY; HIPPOCAMPUS; MALE; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; WESTERN BLOTTING; ANIMAL; ANOXIA; DEFICIENCY; DISEASE MODEL; DOSE RESPONSE; DRUG EFFECTS; IN VITRO STUDY; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; SIGNAL TRANSDUCTION; WISTAR RAT;

BERBERIS; RATTUS NORVEGICUS; ZIZIPHUS MAURITIANA;

ANIMALS; ANOXIA; APOPTOSIS; BERBERINE; BRAIN ISCHEMIA; CASPASE 3; CELL SURVIVAL; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; GLUCOSE; GLYCOGEN SYNTHASE KINASE 3; HIPPOCAMPUS; IN VITRO TECHNIQUES; MALE; MAP KINASE SIGNALING SYSTEM; NEUROPROTECTIVE AGENTS; PROTO-ONCOGENE PROTEINS C-AKT; RATS; RATS, WISTAR;

EID: 84896546507     PISSN: 00068993     EISSN: 18726240     Source Type: Journal    
DOI: 10.1016/j.brainres.2014.02.021     Document Type: Article

References (36)

1. Bendel, O., Bueters, T., von Euler, M., Ogren, S., Sandin, J., von Euler, G., 2005. Reappearance of hippocampal CA1 neurons after ischemia is associated with recovery of learning and memory. J. Cereb. Blood Flow Metab. 25, 1586-1595. (Pubitemid 41683170)
2. Birdsall, T.C., Kelly, G.S., 1997. Berberine: therapeutic potential of an alkaloid found in several medicinal plants. Altern. Med. Rev. 2, 94-103. (Pubitemid 127735667)
3. Chen, J., Nagayama, T., Jin, K., 1998. Induction of caspase-3-like protease may mediate delayed neuronal death in the hippocampus after transient cerebral ischemia. J. Neurosci. 18, 4914-4928.
4. Cimarosti, H., Rodnight, R., Tavares, A., Paiva, R., Valentim, L., Rocha, E., Salbego, C., 2001. An investigation of neuroprotective effect of lithium in organotypic slice cultures of rat hippocampus exposed to oxygen and glucose deprivation. Neurosci. Lett. 315, 33-36. (Pubitemid 33049992)
5. Cui, H.S., Matsumoto, K., Murakami, Y., Hori, H., Zhao, Q., Obi, R., 2009. Berberine exerts neuroprotective actions against in vitro ischemia-induced neuronal cell damage in organotypic hippocampal slice cultures: involvement of B-cell lymphoma 2 phosphorylation suppression. Biol. Pharm. Bull. 32, 79-85.
6. Di Pierro, F., Villanova, N., Agostini, F., Marzocchi, R., Soverini, V., Marchesini, G., 2012. Pilot study on the additive effects of berberine and oral type 2 diabetes agents for patients with suboptimal glycemic control. Diabetes Metab. Syndr. Obes. 5, 213-217.
7. Downward, J., 1998. Mechanisms and consequences of activation of protein Kinase B/Akt. Curr. Opin. Cell Biol. 10, 262-267. (Pubitemid 28174769)
8. Eom, K.S., Hong, J.M., Youn, M.J., So, H.S., Park, R., Kim, J.M., Kim, T.Y., 2008. Berberine induces G1 arrest and apoptosis in human glioblastoma T98G cells through mitochondrial/caspasespathway. Biol. Pharm. Bull. 31 (4), 558-562. (Pubitemid 351500476)
9. Frozza, R.L., Bernardi, A., Hoppe, J.B., Meneghetti, A.B., Matté, A., Battastini, A.M.O., Pohlmann, A.R., Guterres, S.S., Salbego, C.G., 2013. Neuroprotective effects of resveratrol against Aβ administration in rats are improved by lipid-core nanocapsules. Mol. Neurobiol. 47, 1066-1080.
10. Hall, A.A., Leonardo, C.C., Collier, L.A., Rowe, D.D., Willing, A.E., Pennypacker, K.R., 2009. Delayed treatments for stroke influence neuronal death in rat organotypic slice cultures subjected to oxygen glucose deprivation. Neuroscience 164 (2), 470-477.
11. Horn, A.P., Gerhardt, D., Geyer, A.G., Valentim, L., Cimarosti, H., Tavares, A., Horn, F., Lenz, G., Salbego, C., 2005. Cellular death in hippocampus in response to PI3K pathway inhibition and oxygen and glucose deprivation. Neurochem. Res. 30 (3), 355-361. (Pubitemid 40880811)
12. Ji, H.F., Shen, L., 2011. Berberine: a potential multipotent natural product to combat Alzheimer's disease. Molecules 16 (8), 6732-6740.
13. Kelly, S., Zhao, H., Hua Sun, G., Cheng, D., Qiao, Y., Luo, J., Martin, K., Steinberg, G.K., Harrison, S.D., Yenari, M.A., 2004. Glycogen synthase kinase 3beta inhibitor Chir025 reduces neuronal death resulting from oxygen-glucose deprivation, glutamate excitotoxicity, and cerebral ischemia. Exp. Neurol. 188 (2), 378-386. (Pubitemid 38891598)
14. Kirino, T., 1982. Delayed neuronal death in the gerbil hippocampus following ischemia. Brain Res. 239, 57-69. (Pubitemid 12101768)
15. Kulkarni, S.K., Dhir, A., 2010. Berberine: a plant alkaloid with therapeutic potential for central nervous system disorders. Phytother. Res. 24, 317-324.
16. Lipton, P., 1999. Ischemic cell death in brain neurons. Physiol. Rev. 79 (4), 1431-1568. (Pubitemid 29473320)
17. Loberg, R.D., Vesely, E., Brosius 3rd, F.C., 2002. Enhanced glycogen synthase kinase-3beta activity mediates hypoxia-induced apoptosis of vascular smooth muscle cells and is prevented by glucose transport and metabolism. J. Biol. Chem. 277 (44), 41667-41673. (Pubitemid 35257473)
18. Mehta, S.L., Manhas, N., Raghubir, R., 2007. Molecular targets in cerebral ischemia for developing novel therapeutics. Brain Res. Rev. 54, 34-66. (Pubitemid 46498164)
19. Moulin, N., Widmann, C., 2004. Islet-brain (IB)/JNK-interacting proteins (JIPs): future targets for the treatment of neurodegenerative diseases?. Curr. Neurovasc. Res. 1 (2), 111-127.
20. Noraberg, J., Kristensen, B.W., Zimmer, J., 1999. Markers for neuronal degeneration in organotypic slice cultures. Brain Res. Protocol. 3, 278-290. (Pubitemid 29023528)
21. Noraberg, J., Poulsen, F.R., Blaabjerg, M., Kristensen, B.W., Bonde, C., Montero, M., Meyer, M., Gramsbergen, J.B., Zimmer, J., 2005. Organotypic hippocampal slice cultures for studies of brain damage, neuroprotection and neurorepair. Curr. Drug Targets CNS Neurol. Disord. 4, 435-452. (Pubitemid 41086760)
22. Ouyang, Y., Tan, Y., Comb, M., Liu, C., Martone, M.E., Siesjo, B.K., Hu, B., 1999. Survival- and death-promoting events after transient cerebral ischemia: phosphorylation of Akt, release of cytochrome c, and activation of caspase-like proteases. J. Cereb. Blood Flow Metab. 19, 1126-1135. (Pubitemid 30167763)
23. Simão F., Matté A., Pagnussat A.S., Netto C.A., Salbego C.G., 2012. Resveratrol preconditioning modulates inflammatory response in the rat hippocampus following global cerebral ischemia. Neurochem. Int. 5,l 659-65.
24. Stoppini, L., Buchs, P.A., Muller, D., 1991. A simple method for organotypic cultures of nervous tissue. J. Neurosci. Methods 37, 173-182.
25. Strasser, U., Fischer, G., 1995. Quantitative measurement of neuronal degeneration in organotypic hippocampal cultures after combined oxygen/glucose deprivation. J. Neurosci. Methods 57, 177-186.
26. Sugawara, T., Fujimura, M., Noshita, N., Kim, G.W., Saito, A., Hayashi, T., Narasimhan, P., Maier, C.M., Chan, P.H., 2004. Neuronal death/survival signaling pathways in cerebral ischemia. J. Am. Soc. Exp. NeuroTher. 1, 17-25. (Pubitemid 46589339)
27. Valentim, L.M., Rodnight, R., Geyer, A.B., Horn, A.P., Tavares, A., Cimarosti, H., Netto, C.A., Salbego, C.G., 2003. Changes in heat shock protein 27 phosphorylation and immunocontent in response to preconditioning to oxygen and glucose deprivation in organotypic hippocampal cultures. Neuroscience 118, 379-386. (Pubitemid 36423253)
28. Wang, F., Zhao, G., Cheng, L., Zhou, H.Y., Fu, L.Y., Yao, W.X., 2004. Effects of berberine on potassium currents in acutely isolated CA1 pyramidal neurons of rat hippocampus. Brain Res. 999, 91-97. (Pubitemid 38121454)
29. Wang, Q., Zhang, Q.G., Wu, D.N., Yin, X.H., Zhang, G.Y., 2007. Neuroprotection of selenite against ischemic brain injury through negatively regulating early activation of ASK1/JNK cascade via activation of PI3K/AKT pathway. Acta Pharmacol. Sin. 28 (1), 19-27. (Pubitemid 46046622)
30. Wu, Y.H., Chuang, S.Y., Hong, W.C., Lai, Y.J., Chang, G.J., Pang, J.H., 2012. Berberine reduces leukocyte adhesion to LPS-stimulated endothelial cells and VCAM-1 expression both in vivo and in vitro. Int. J. Immunopathol. Pharmacol. 25 (3), 741-750.
31. Yasuda, Y., Shimoda, T., Uno, K., Tateishi, N., Furuya, S., Tsuchihashi, Y., Kawai, Y., Naruse, S., Fujita, S., 2011. Temporal and sequential changes of glial cells and cytokine expression during neuronal degeneration after transient global ischemia in rats. J. Neuroinflamm. 22 (8), 70.
32. Yoo, K.Y., Hwang, I.K., Lim, B.O., Kang, T.C., Kim, D.W., Kim, S.M., Lee, H.Y., Kim, J.D., Won, M.H., 2006. Berberry extract reduces neuronal damage and N-methyl-D-aspartate receptor 1 immunoreactivity in the gerbil hippocampus after transient forebrain ischemia. Biol. Pharm. Bull. 29, 623-628.
33. Zamin, L.L., Dillenburg-Pilla, P., Argenta-Comiran, R., Horn, A.P., Simão, F., Nassif, M., Gerhardt, D., Frozza, R.L., Salbego, C., 2006. Protective effect of resveratrol against oxygen-glucose deprivation in organotypic hippocampal slice cultures: involvement of PI3K pathway. Neurobiol. Dis. 24, 170-182. (Pubitemid 44416216)
34. Zhang, Q., Qian, Z., Pan, L., Li, H., Zhu, H., 2012. Hypoxiainducible factor 1 mediates the anti-apoptosis of berberine in neurons during hypoxia/ischemia. Acta. Physiol. Hung. 99 (3), 311-323.
35. Zhou, X.Q., Zeng, X.N., Kong, H., Zun, X.L., 2008. Neuroprotective effects of berberine on stroke models in vitro and in vivo. Neurosci. Lett. 447, 31-36.
36. Zhu, F., Qian, C., 2006. Berberine chloride can ameliorate the spatial memory impairment and increase the expression of interleukin-1beta and inducible nitric oxide synthase in the rat model of Alzheimer's disease. BMC Neurosci. 7, 78.